Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07668102 · ClinicalTrials.gov registry record · NA
Visual Performance of Highly Aspherical Lenslet Spectacles in Children (Ancillary to WS10246)
A NA study, sponsored by Essilor International.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT07668102 is a NA study that has completed, run by Essilor International. The registered enrollment target is 88 participants.
The verdict
NCT07668102, a NA study, has completed, sponsored by Essilor International.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
To evaluate the visual performance of (high and low contrast distance visual acuity, reading speed, near visual acuity, and near contrast sensitivity) of HAL spectacle lenses (habitual correction) in comparison with single vision control lenses.
Interventions
- DEVICE HAL spectacle lens
- DEVICE Single Vision spectacle lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2024-05-22 |
| Est. Completion | 2024-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07668102
The ClinicalTrials.gov registry entry for NCT07668102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Essilor International, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HAL spectacle lens is the first listed.
NCT07668102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07668102 about?
NCT07668102 is a clinical study titled "Visual Performance of Highly Aspherical Lenslet Spectacles in Children (Ancillary to WS10246)". To evaluate the visual performance of (high and low contrast distance visual acuity, reading speed, near visual acuity, and near contrast sensitivity) of HAL spectacle lenses (habitual correction) in comparison with single vision control lenses.
What is the current status of trial NCT07668102?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2024-05-22. Estimated completion is 2024-10-20.
What interventions are being tested in trial NCT07668102?
The interventions under investigation include: HAL spectacle lens (DEVICE), Single Vision spectacle lens (DEVICE).
Who is sponsoring clinical trial NCT07668102?
This trial is sponsored by Essilor International, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.